The cell banking outsourcing market is witnessing strong growth driven by increasing demand for biologics, rising adoption of cell and gene therapies, and growing investment in regenerative medicine and biopharmaceutical research. North America currently lead…
The India cell-based assay market is poised for growth due to increased drug discovery activities, automation in high-throughput screening, and outsourcing to CROs. Opportunities exist in 3D cell culture models, AI integration, stem cell research, oncology, a…